Daniel Lochner

Insider Reports History

Entity
Individual
Location
202 Carnegie Center, Suite 106, Princeton, NJ
Signature
/s/ Daniel Lochner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lochner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tectonic Therapeutic, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 118K Jun 20, 2024 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Performance Stock Units 0 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 Jan 3, 2023 Direct

Insider Reports Filed by Daniel Lochner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Chief Financial Officer
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Dec 1, 2022 1 -$36.5K 4 Dec 6, 2022 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Jul 6, 2022 1 $0 4 Jul 8, 2022 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Jan 29, 2022 9 -$11K 4 Jan 4, 2023 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Jan 9, 2022 2 $0 4 Jan 11, 2022 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Nov 1, 2021 2 $98.9K 4 Nov 2, 2021 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Sep 2, 2021 2 $86.3K 4 Sep 7, 2021 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Aug 26, 2021 1 $0 4 Aug 30, 2021 Chief Financial Officer
OYST Oyster Point Pharma, Inc. Jul 28, 2021 2 $86.3K 4 Jul 29, 2021 Chief Financial Officer